| | | | | Präparat | Packungsgrösse | EFP | PP | SB | TK | Zusammensetzung | Zulassungsinhaber | Kat. | | | | |
---|
|
| | FI | PI | | Qvar Autohaler 100 µg | 200 Inhalation(en) | 20.00 | 38.15 | 10% | | Dosier-Aerosol: Beclometasoni Dipropionas 100 µg | Teva Pharma AG | B / SL | FB | | G |  |
| | FI | PI | | Beclo Orion Easyhaler | 200 | 28.79 | 47.75 | 10% | | Inhalationspulver: Beclometasoni Dipropionas 200 µg | Orion Pharma AG | B / SL | FB | | G |  |
| | FI | PI | | Qvar Autohaler 50 µg | 100 Inhalation(en) | PA | PA | k.A. | | Dosier-Aerosol: Beclometasoni Dipropionas 50 µg | Teva Pharma AG | B | FB | | G |  |
| | FI | PI | | Qvar Autohaler 50 µg | 200 Inhalation(en) | PA | PA | k.A. | | Dosier-Aerosol: Beclometasoni Dipropionas 50 µg | Teva Pharma AG | B | FB | | G |  |
| | FI | PI | | Qvar Autohaler 100 µg | 100 Inhalation(en) | PA | PA | k.A. | | Dosier-Aerosol: Beclometasoni Dipropionas 100 µg | Teva Pharma AG | B | FB | | G |  |
|
| | FI | PI | | Pulmicort Respules 0,25 mg/mL | 20 1 Ampulle(n) à 2 ml | 21.29 | 39.20 | 10% | | Suspension: Budesonidum | AstraZeneca AG | B / SL / SO | FB | | G |  |
| | FI | PI | | Pulmicort Respules 0,5 mg/mL | 20 1 Ampulle(n) à 2 ml | 39.32 | 58.60 | 10% | | Suspension: Budesonidum | AstraZeneca AG | B / SL / SO | FB | | G |  |
| | FI | PI | | Miflonide Breezhaler 200 mcg | 60 | 9.12 | 26.35 | 10% | | Inhalationspulver: Budesonidum 200 µg | Novartis Pharma Schweiz AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Miflonide Breezhaler 400 mcg | 60 | 18.24 | 36.25 | 10% | | Inhalationspulver: Budesonidum 400 µg | Novartis Pharma Schweiz AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Budenid Steri-Nebs 0.5mg/2ml | 20 Stück | 15.37 | 33.15 | 10% | | Gebrauchsfertige Suspension für Aerosolgeräte: Budesonidum | Teva Pharma AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Budenid Steri-Nebs 1mg/2ml | 20 Stück | 29.96 | 49.00 | 10% | | Gebrauchsfertige Suspension für Aerosolgeräte: Budesonidum | Teva Pharma AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Pulmicort Turbuhaler 100 | 200 Einzeldosen | 16.90 | 34.80 | 10% | | Inhalationspulver: Budesonidum 100 µg | AstraZeneca AG | B / SL | FB | | G |  |
| | FI | PI | | Pulmicort Turbuhaler 200 | 200 Einzeldosen | 33.78 | 53.15 | 10% | | Inhalationspulver: Budesonidum 200 µg | AstraZeneca AG | B / SL | FB | | G |  |
| | FI | PI | | Pulmicort Turbuhaler 400 | 50 Einzeldosen | 16.90 | 34.80 | 10% | | Inhalationspulver: Budesonidum 400 µg | AstraZeneca AG | B / SL | FB | | G |  |
| | FI | PI | | Pulmicort Respules 0,125 mg/mL | 20 1 Ampulle(n) à 2 ml | 16.82 | 34.70 | 10% | | Suspension: Budesonidum | AstraZeneca AG | B / SL | FB | | G |  |
| | FI | PI | | Budenid Steri-Nebs 0.5mg/2ml | 60 Stück | PA | PA | k.A. | | Gebrauchsfertige Suspension für Aerosolgeräte: Budesonidum | Teva Pharma AG | B | FB | | G |  |
| | FI | PI | | Budenid Steri-Nebs 1mg/2ml | 60 Stück | PA | PA | k.A. | | Gebrauchsfertige Suspension für Aerosolgeräte: Budesonidum | Teva Pharma AG | B | FB | | G |  |
|
| | FI | PI | | Axotide 50 | Inhalation(en) à 0.05 mg | 7.73 | 17.65 | 10% | | Dosier-Aerosol: Fluticasoni Propionas 50 µg | GlaxoSmithKline AG | ● B / SL | FB | | G |  |
| | FI | PI | | Axotide 125 | Inhalation(en) à 0.125 mg | 16.87 | 34.75 | 10% | | Dosier-Aerosol: Fluticasoni Propionas 125 µg | GlaxoSmithKline AG | ● B / SL | FB | | G |  |
| | FI | PI | | Axotide 250 | Inhalation(en) à 0.25 mg | 26.84 | 45.60 | 10% | | Dosier-Aerosol: Fluticasoni Propionas 250 µg | GlaxoSmithKline AG | ● B / SL | FB | | G |  |
| | FI | PI | | Axotide Diskus 100 | 60 Inhalation(en) | 7.73 | 17.65 | 10% | | Mutlidosen-Pulverinhalator: Fluticasoni Propionas 100 µg | GlaxoSmithKline AG | B / SL | FB | | G |  |
| | FI | PI | | Axotide Diskus 250 | 60 Inhalation(en) | 16.87 | 34.75 | 10% | | Mutlidosen-Pulverinhalator: Fluticasoni Propionas 250 µg | GlaxoSmithKline AG | B / SL | FB | | G |  |
| | FI | PI | | Axotide Diskus 500 | 60 Inhalation(en) | 26.84 | 45.60 | 10% | | Mutlidosen-Pulverinhalator: Fluticasoni Propionas 500 µg | GlaxoSmithKline AG | B / SL | FB | | G |  |
| | FI | PI | | Axotide Nebules 0,5 mg/2 mL | 10 Einzeldosen | 9.06 | 18.60 | k.A. | | gebrauchsfertige Suspension zur Inhalation: Fluticasoni-17 Propionas | GlaxoSmithKline AG | B | FB | | G |  |
| | FI | PI | | Axotide Nebules 2 mg/2 mL | 10 Einzeldosen | 32.80 | 54.05 | k.A. | | gebrauchsfertige Suspension zur Inhalation: Fluticasoni-17 Propionas 2 mg | GlaxoSmithKline AG | B | FB | | G |  |
|
| KFI | FI | PI | | Alvesco 80 ug | 120 Inhalation(en) | 20.33 | 38.55 | 10% | | Dosier-Aerosol: Ciclesonidum 80 µg | Covis Pharma GmbH | B / SL | FB | | G |  |
| KFI | FI | PI | | Alvesco 160 ug | 120 Inhalation(en) | 25.45 | 44.10 | 10% | | Dosier-Aerosol: Ciclesonidum 160 µg | Covis Pharma GmbH | B / SL | FB | | G |  |
|
| | FI | PI | | Arnuity Ellipta 90 mcg | 30 Einzeldosen | 15.60 | 33.40 | 10% | | Einzeldosiertes Pulver zur Inhalation: Fluticasoni Furoas 90 µg | GlaxoSmithKline AG | B / SL | FB | | G |  |
| | FI | PI | | Arnuity Ellipta 90 mcg | 3 x 30 | 46.80 | 67.30 | 10% | | Einzeldosiertes Pulver zur Inhalation: Fluticasoni Furoas 90 µg | GlaxoSmithKline AG | B / SL | FB | | G |  |
| | FI | PI | | Arnuity Ellipta 182 mcg | 30 Einzeldosen | 25.58 | 44.25 | 10% | | Einzeldosiertes Pulver zur Inhalation: Fluticasoni Furoas 182 µg | GlaxoSmithKline AG | B / SL | FB | | G |  |
| | FI | PI | | Arnuity Ellipta 182 mcg | 3 x 30 | 76.74 | 99.90 | 10% | | Einzeldosiertes Pulver zur Inhalation: Fluticasoni Furoas 182 µg | GlaxoSmithKline AG | B / SL | FB | | G |  |
| | FI | | | Arnuity Ellipta 46 mcg | 30 | PA | PA | k.A. | | Einzeldosiertes Pulver zur Inhalation: Fluticasoni Furoas 46 µg | GlaxoSmithKline AG | B | FB | | G |  |
|
| | FI | PI | | Atrovent 250 mcg/2 ml | 60 Einzeldosen | 17.33 | 34.85 | 10% | | Lösung für einen Vernebler (gebrauchsfertige Einzeldosen): Ipratropii Bromidum Anhydricum 250µg / 2ml | Boehringer Ingelheim (Schweiz) GmbH | B / SL / SO | FB | | G |  |
| | FI | PI | | Atrovent N | 200 Inhalation(en) | 9.52 | 26.75 | 10% | | Dosier-Aerosol: Ipratropii Bromidum 21 µg | Boehringer Ingelheim (Schweiz) GmbH | B / SL | FB | | G |  |
| | | PI | | Atrovent | 15 ml | 13.12 | 29.80 | k.A. | | Dosier-Aerosol: Ipratropii Bromidum 20 µg | Boehringer Ingelheim (Schweiz) GmbH | B | FB | | G |  |
|
| KFI | FI | PI | | Spiriva 18 mcg | 30 Kapsel(n) | 29.98 | 49.00 | 10% | | Inhalationspulver: Tiotropium 18 µg | Boehringer Ingelheim (Schweiz) GmbH | B / SL | FB | | G |  |
| KFI | FI | PI | | Spiriva 18 mcg | 90 Kapsel(n) | 88.66 | 112.85 | 10% | | Inhalationspulver: Tiotropium 18 µg | Boehringer Ingelheim (Schweiz) GmbH | B / SL | FB | | G |  |
| | FI | PI | | Spiriva Respimat 2.5 mcg | | 29.98 | 49.00 | 10% | | Lösung zur Inhalation (wiederverwendbar): Tiotropium 2.5 µg | Boehringer Ingelheim (Schweiz) GmbH | B / SL | FB | | G |  |
| | FI | PI | | Spiriva Respimat 2.5 mcg | 3 | 88.66 | 112.85 | 10% | | Lösung zur Inhalation (wiederverwendbar): Tiotropium 2.5 µg | Boehringer Ingelheim (Schweiz) GmbH | B / SL | FB | | G |  |
|
| | FI | PI | PS | Eklira Genuair | Stück | 37.46 | 57.15 | 10% | | Inhalationspulver: Aclidinii Bromidum 375 µg | Covis Pharma GmbH | B / SL | FB | | G |  |
| | FI | PI | PS | Eklira Genuair | 3 Stück | 103.54 | 129.00 | 10% | | Inhalationspulver: Aclidinii Bromidum 375 µg | Covis Pharma GmbH | B / SL | FB | | G |  |
|
| | FI | PI | PS | Seebri Breezhaler | 30 Kapsel(n) | 35.38 | 54.90 | 10% | | Mikrogramm: Glycopyrronium 50 µg | Novartis Pharma Schweiz AG | B / SL | FB | | G |  |
| | FI | PI | PS | Seebri Breezhaler | 90 Kapsel(n) | 106.13 | 131.85 | 10% | | Mikrogramm: Glycopyrronium 50 µg | Novartis Pharma Schweiz AG | B / SL | FB | | G |  |
|
| | FI | PI | | Incruse Ellipta | 30 Einzeldosen | 34.64 | 54.10 | 10% | | Inhalationspulver: Umeclidinium 62.5 µg | GlaxoSmithKline AG | B / SL | FB | | G |  |
| | FI | PI | | Incruse Ellipta | 3 x 30 Einzeldosen | 103.00 | 128.45 | 10% | | Inhalationspulver: Umeclidinium 62.5 µg | GlaxoSmithKline AG | B / SL | FB | | G |  |